Aulos Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $60M

  • Investors
  • 2

Aulos General Information

Description

Operator of a biotechnology company intended to direct patients' immune systems toward killing tumor cells. The company's platform applies machine-learning-guided antibody design, advanced immune-pathway targeting, and precise clinical candidate development, enabling oncology researchers and clinicians focused on solid tumors to advance investigational interleukin-2-based therapies with the potential to improve immune activation and patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 700 Larkspur Landing Circle
  • Suite 108
  • Larkspur, CA 94939
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 700 Larkspur Landing Circle
  • Suite 108
  • Larkspur, CA 94939
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aulos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A1) 10-Aug-2023 $60M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 08-Jan-2021 Completed Clinical Trials - Phase 2
To view Aulos’s complete valuation and funding history, request access »

Aulos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
To view Aulos’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aulos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to direct patients' immune systems toward killing tumor cells. The company'
Drug Discovery
Larkspur, CA
9 As of 2022

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aulos Competitors (1)

One of Aulos’s competitors is Fate Therapeutics, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Fate Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 1 of 1 competitors. Get the full list »

Aulos Patents

Aulos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260132195-A1 Anti-il-2 antibody combinations and methods of use thereof Pending 04-Jan-2024
US-20260183390-A1 Anti-il-2 antibody combinations and methods of use thereof Pending 10-Nov-2022
US-20260199460-A1 Anti-il-2 antibody combinations and methods of use thereof Pending 10-Nov-2022
US-20260207741-A1 Anti-il-2 antibody combinations and methods of use thereof Pending 10-Nov-2022
US-20260274942-A1 Anti-il-2 antibody combinations and methods of use thereof Pending 10-Nov-2022 C07K16/246
To view Aulos’s complete patent history, request access »

Aulos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aulos Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biolojic Design VC-Backed Company Minority
Apple Tree Partners (ATP) Venture Capital Minority
To view Aulos’s complete investors history, request access »

Aulos FAQs

  • When was Aulos founded?

    Aulos was founded in 2020.

  • Where is Aulos headquartered?

    Aulos is headquartered in Larkspur, CA.

  • What is the size of Aulos?

    Aulos has 9 total employees.

  • What industry is Aulos in?

    Aulos’s primary industry is Drug Discovery.

  • Is Aulos a private or public company?

    Aulos is a Private company.

  • What is the current valuation of Aulos?

    The current valuation of Aulos is .

  • What is Aulos’s current revenue?

    The current revenue for Aulos is .

  • How much funding has Aulos raised over time?

    Aulos has raised $100M.

  • Who are Aulos’s investors?

    Biolojic Design and Apple Tree Partners (ATP) have invested in Aulos.

  • Who are Aulos’s competitors?

    Fate Therapeutics is a competitor of Aulos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process